News for Healthier Living

Blood Test Predicts Immunotherapy Benefit Early Among Patients With Advanced Lung Cancer

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy -- a blood test that detects circulating tumor DNA (ctDNA) -- can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy.

August 3, 2026


August 4 2026

August 3 2026

August 1 2026

July 31 2026

July 30 2026

July 29 2026

July 28 2026

July 27 2026

July 26 2026

July 25 2026

July 24 2026

July 23 2026

July 22 2026

July 21 2026